Quick Answer
Ingevity Corp reported Total Revenue of $1.17 billion for fiscal year 2025.
Ingevity Corp — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $1.17B -2.7% |
$1.20B -1.3% |
$1.22B -27.1% |
$1.67B +19.9% |
$1.39B +14.4% |
$1.22B -5.9% |
| Revenue (ASC 606) | $1.17B -2.7% |
$1.20B -1.3% |
$1.22B -27.1% |
$1.67B +19.9% |
$1.39B +14.4% |
$1.22B -5.9% |
| Net Income | -$167.10M +61.2% |
-$430.30M -7868.5% |
-$5.40M -102.6% |
$211.60M +79.2% |
$118.10M -34.9% |
$181.40M -1.3% |
| Diluted EPS | -$4.61 +61.1% |
-$11.85 -7800.0% |
-$0.15 -102.7% |
$5.50 +86.4% |
$2.95 -32.5% |
$4.37 +0.5% |
| Total Assets | $1.65B -18.4% |
$2.02B -22.9% |
$2.62B -4.1% |
$2.74B +10.8% |
$2.47B +5.8% |
$2.33B +9.0% |
| Cash and Equivalents | $78.10M +14.9% |
$68.00M -29.1% |
$95.90M +25.0% |
$76.70M -72.1% |
$275.40M +6.9% |
$257.70M +356.1% |
| Stockholders Equity | $29.70M -84.8% |
$195.20M -69.1% |
$631.40M -9.6% |
$698.30M +3.6% |
$673.80M +4.9% |
$642.10M +21.0% |
| R&D Expense | $28.40M +15.9% |
$24.50M -3.5% |
$25.40M -16.2% |
$30.30M +15.2% |
$26.30M +16.4% |
$22.60M +14.7% |
| Gross Profit | $461.50M -0.7% |
$464.80M +4.4% |
$445.00M -21.9% |
$570.10M +11.2% |
$512.80M +10.2% |
$465.50M -3.4% |
| Shares Outstanding | 35.49M -2.4% |
36.35M +0.3% |
36.23M -2.9% |
37.30M -5.0% |
39.27M -3.1% |
40.51M -3.1% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $333.10M | -0.2% | -8.8% |
| Revenue (ASC 606) | September 30, 2025 | $333.10M | -0.2% | -8.8% |
| Net Income | September 30, 2025 | $43.50M | +140.6% | +129.7% |
| Diluted EPS | September 30, 2025 | $1.18 | +140.1% | +129.4% |
| Total Assets | September 30, 2025 | $1.83B | -17.1% | -2.3% |
| Cash and Equivalents | September 30, 2025 | $83.40M | -38.5% | +8.5% |
| Stockholders Equity | September 30, 2025 | $138.10M | -35.6% | +14.4% |
| R&D Expense | September 30, 2025 | $7.00M | +12.9% | -10.3% |
| Gross Profit | September 30, 2025 | $133.90M | +1.7% | -2.9% |
| Shares Outstanding | September 30, 2025 | 36.05M | -0.8% | -1.1% |
- Ingevity Corp reported Total Revenue of $1.17 billion for fiscal year 2025.
- Ingevity Corp showed a decrease of -2.7% in Total Revenue compared to the prior fiscal year.
- Ingevity Corp reported Revenue (ASC 606) of $1.17 billion for fiscal year 2025.
- Ingevity Corp showed a decrease of -2.7% in Revenue (ASC 606) compared to the prior fiscal year.
- Ingevity Corp reported Net Income of -$167.10 million for fiscal year 2025.
- Ingevity Corp showed an increase of +61.2% in Net Income compared to the prior fiscal year.
- Ingevity Corp reported Diluted EPS of $4.61 per share (loss) for fiscal year 2025.
- Ingevity Corp showed an increase of +61.1% in Diluted EPS compared to the prior fiscal year.
- Ingevity Corp reported Total Assets of $1.65 billion for fiscal year 2025.
- Ingevity Corp showed a decrease of -18.4% in Total Assets compared to the prior fiscal year.
- Ingevity Corp reported Cash and Equivalents of $78.10 million for fiscal year 2025.
- Ingevity Corp showed an increase of +14.9% in Cash and Equivalents compared to the prior fiscal year.
- Ingevity Corp reported Stockholders Equity of $29.70 million for fiscal year 2025.
- Ingevity Corp showed a decrease of -84.8% in Stockholders Equity compared to the prior fiscal year.
- Ingevity Corp reported R&D Expense of $28.40 million for fiscal year 2025.
- Ingevity Corp showed an increase of +15.9% in R&D Expense compared to the prior fiscal year.
- Ingevity Corp reported Gross Profit of $461.50 million for fiscal year 2025.
- Ingevity Corp showed a decrease of -0.7% in Gross Profit compared to the prior fiscal year.
- Ingevity Corp reported Shares Outstanding of 35.49 million shares for fiscal year 2025.
- Ingevity Corp showed a decrease of -2.4% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: